Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

4,776 questions · 7,311 findings · 959 reviews · Headline outcomes only

No studies found 1,498 · 20.5%GRADE not reported 303 · 4.1%Very low 1,839 · 25.2%Low 1,991 · 27.2%Moderate 1,277 · 17.5%High 403 · 5.5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Vaginal PGE2 vs intravenous (IV) oxytocin

Serious neonatal morbidity or perinatal death · women with one previous lower segment caesarean section and requiring labour induction due to prolonged pregnancy or pre‐eclampsia,…

Vaginal PGE2 showed no clear difference in serious neonatal morbidity/perinatal death compared with intravenous (IV) oxytocin (low certainty).

1 finding from 1 review

Psychosocial interventions vs control

Mental well‐being at · promoting the mental health of people living in LMICs affected by humanitarian crises (children)
2 findings from 1 review

Psychosocial interventions vs control

Functioning at · promoting the mental health of people living in LMICs affected by humanitarian crises (children)
2 findings from 1 review

Psychosocial interventions vs control

Prosocial behaviour at · promoting the mental health of people living in LMICs affected by humanitarian crises (children)
2 findings from 1 review

Psychosocial interventions vs control

Mental well‐being at · promoting the mental health of people living in LMICs affected by humanitarian crises (adults)
2 findings from 1 review

Antioxidant multivitamin and mineral supplement vs placebo or no treatment

Progression to late AMD (neovascular AMD, geographic atrophy or both) · people with AMD

Antioxidant multivitamin and mineral supplement probably leads to lower progression to late AMD (neovascular AMD, geographic atrophy, or both) compared with placebo or no treatment (moderate certainty).

1 finding from 1 review

Lutein with or without zeaxanthin vs placebo

Progression to visual loss (loss of 3 or more lines on logMAR chart) · people with AMD

Lutein with or without zeaxanthin showed no clear difference in progression to visual loss (loss of 3 or more lines on logMAR chart) compared with placebo (low certainty).

1 finding from 1 review